AVITA Medical (RCEL) Receivables - Net (2018 - 2026)

AVITA Medical's (RCEL) quarterly Receivables - Net came in at $9.1 million in Q4 2025, up 0.81% on a QoQ basis from $9.0 million in Q3 2025.

AVITA Medical (RCEL) Receivables - Net (2018 - 2026) Analysis & Trends

AVITA Medical (RCEL) has 8 years of Receivables - Net data on file, last reported at $9.1 million in Q4 2025.

Quarterly Receivables - Net changed N/A year-over-year to $9.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.1 million (changed N/A YoY) and the FY2025 annual result came in at $9.1 million, down 22.91% from the prior year.
Receivables - Net climbed to $9.1 million in Q4 2025, from $9.0 million in the prior quarter.
In the past five years, Receivables - Net ranged from a high of $12.0 million in Q1 2025 to a low of $2.2 million in Q1 2021.
A 5-year average of $6.5 million and a median of $5.9 million in 2023 frame the typical range for Receivables - Net.
Annual changes were most pronounced in 2024 — Receivables - Net soared 75.11% — and 2025, when it slipped 12.39%.
Tracing RCEL's Receivables - Net over 5 years: stood at $3.1 million in 2021, then increased by 13.95% to $3.6 million in 2022, then surged by 115.71% to $7.7 million in 2023, then soared by 34.24% to $10.3 million in 2024, then slipped by 11.68% to $9.1 million in 2025.
The last three Receivables - Net figures came in at $9.1 million (Q4 2025), $9.0 million (Q3 2025), and $11.3 million (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn
10	AVITA Medical	309.96 Mn	298.82 Mn	17.77 Mn

Download Data